Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.520
-0.070 (-4.40%)
Nov 21, 2024, 4:00 PM EST - Market closed
Atai Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | - | -40.22 | -152.39 | -167.81 | -169.84 | -14.14 |
| Depreciation & Amortization | - | 0.32 | 0.17 | 0.05 | 0.02 | 0.01 |
| Other Amortization | - | 0.37 | 0.13 | 0.2 | 0.06 | - |
| Loss (Gain) From Sale of Assets | - | -0.06 | -1.48 | - | - | - |
| Asset Writedown & Restructuring Costs | - | - | 0.36 | 15.48 | 12.02 | 9.67 |
| Loss (Gain) From Sale of Investments | - | 1.01 | - | -4.58 | -19.86 | 0.63 |
| Loss (Gain) on Equity Investments | - | 3.59 | 16.01 | 58.56 | 76.51 | 6.91 |
| Stock-Based Compensation | - | 32.98 | 42.38 | 63.36 | 67.16 | 0.06 |
| Other Operating Activities | - | -89.58 | -6.3 | -20.9 | 8.71 | -10.86 |
| Change in Accounts Payable | - | 2.14 | -3.03 | 2.3 | 1.7 | 0.25 |
| Change in Unearned Revenue | - | - | - | 0.01 | - | - |
| Change in Other Net Operating Assets | - | 5.33 | -0.3 | -9.92 | 2.75 | -0.38 |
| Operating Cash Flow | - | -84.12 | -104.47 | -63.25 | -20.77 | -7.85 |
| Capital Expenditures | - | -0.26 | -0.77 | -1.17 | -0.06 | -0.02 |
| Divestitures | - | -0.44 | - | - | - | - |
| Sale (Purchase) of Intangibles | - | -0.33 | -0.25 | -0.96 | - | - |
| Investment in Securities | - | -46.75 | -82.82 | -76.6 | -26.01 | -1.24 |
| Other Investing Activities | - | -5.51 | -3 | -2.55 | -2.2 | -7.78 |
| Investing Cash Flow | - | -53.3 | -86.85 | -81.28 | -28.27 | -9.03 |
| Long-Term Debt Issued | - | - | 15 | 4.01 | 32.5 | - |
| Net Debt Issued (Repaid) | - | - | 15 | 4.01 | 32.5 | - |
| Issuance of Common Stock | - | 0.23 | 6.93 | 418.21 | 82.56 | 42.68 |
| Other Financing Activities | - | -8.58 | -1.15 | -12.35 | -2.01 | -2.3 |
| Financing Cash Flow | - | -8.36 | 20.79 | 409.86 | 113.05 | 40.39 |
| Foreign Exchange Rate Adjustments | - | 0.19 | -1.12 | -0.32 | 3.17 | -0.37 |
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | - |
| Net Cash Flow | - | -145.58 | -171.65 | 265.02 | 67.18 | 23.14 |
| Free Cash Flow | - | -84.38 | -105.24 | -64.42 | -20.83 | -7.87 |
| Free Cash Flow Margin | - | -26871.66% | -45167.38% | -316.15% | - | - |
| Free Cash Flow Per Share | - | -0.53 | -0.68 | -0.47 | -0.22 | -0.91 |
| Cash Interest Paid | - | 1.92 | 0.51 | - | - | - |
| Cash Income Tax Paid | - | 1.48 | 0.65 | - | - | - |
| Levered Free Cash Flow | - | -37.17 | -51.63 | -15.6 | -34.43 | - |
| Unlevered Free Cash Flow | - | -35.88 | -51.19 | -15.8 | -34.49 | - |
| Change in Net Working Capital | 23.75 | -7.83 | 2.44 | 1.88 | -17.47 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.